Selective killing of vascular endothelial cells based on adenovirus-mediated herpes simplex virus thymidine kinase gene transfection under the driving of KDR promoter
Qian Long Zhu
Abstract
Qian Long Zhu
Abstract
AIM: To investigate the target killing effect of adenovirus-mediated herpes simplex virus thymidine kinase gene(HSV-tk) transfection under the driving of KDR promoter on the vascular endothelial cells in vitro.METHODS:By using AdEasy system,recombinant adenovirus plasmid containing KDR or cytomegalovirus(CMV) promoter-controlled HSV-tk gene(AdKDR-tk and AdCMV-tk) was constructed.After packaging and amplification in 293 cells,the virus was used to infect KDR-expressed human umbilical venous endothelial cells(HUVEC) and KDR-unexpressed CNE-2.Following administration of ganciclovir(GCV),the survival rate of gene-transfected HUVEC and CNE-2 was evaluated by using MTT method.RESULTS:The AdEasy System produced a high titer of the recombinant adenovirus(1×10~(13) pfu/L).Under infection index of 100,with increasing GCV concentration from 0 up to 50 mg/L, the survival rates of AdKDR-tk-transfected HUVEC and CNE-2 decreased from(89.4±(4.6)%) and(91.5±4.4)% to(22.9±4.7)% and(71.4±(2.9)%) at proper order respectively(P0.01),while the(survival) rates of AdCMV-tk-transfected HUVEC and CNE-2 declined from(89.9±6.2)% and(90.8±5.7)% to(12.8±(2.6)%) and(18.8±6.1)%,respectively(P0.05).(CONCLUSION:)Adenovirus-mediated HSV-tk transfection under the driving of KDR promoter could yield the specific killing effect on vascular endothelial cells with treatment of GCV.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To investigate the target killing effect of adenovirus-mediated herpes simplex virus thymidine kinase gene(HSV-tk) transfection under the driving of KDR promoter on the vascular endothelial cells in vitro.METHODS:By using AdEasy system,recombinant adenovirus plasmid containing KDR or cytomegalovirus(CMV) promoter-controlled HSV-tk gene(AdKDR-tk and AdCMV-tk) was constructed.After packaging and amplification in 293 cells,the virus was used to infect KDR-expressed human umbilical venous endothelial cells(HUVEC) and KDR-unexpressed CNE-2.Following administration of ganciclovir(GCV),the survival rate of gene-transfected HUVEC and CNE-2 was evaluated by using MTT method.RESULTS:The AdEasy System produced a high titer of the recombinant adenovirus(1×10~(13) pfu/L).Under infection index of 100,with increasing GCV concentration from 0 up to 50 mg/L, the survival rates of AdKDR-tk-transfected HUVEC and CNE-2 decreased from(89.4±(4.6)%) and(91.5±4.4)% to(22.9±4.7)% and(71.4±(2.9)%) at proper order respectively(P0.01),while the(survival) rates of AdCMV-tk-transfected HUVEC and CNE-2 declined from(89.9±6.2)% and(90.8±5.7)% to(12.8±(2.6)%) and(18.8±6.1)%,respectively(P0.05).(CONCLUSION:)Adenovirus-mediated HSV-tk transfection under the driving of KDR promoter could yield the specific killing effect on vascular endothelial cells with treatment of GCV.
Key concepts: Thymidine kinase, Transfection, Herpes simplex virus, Ganciclovir, Molecular biology, Genetic enhancement, Biology, Umbilical vein